Contributions of Antibiotic Penetration, Oxygen Limitation, and Low Metabolic Activity to Tolerance of Pseudomonas aeruginosa Biofilms to Ciprofloxacin and Tobramycin
By Marshall C Walters, F. Roe, Amandine Bugnicourt, M. Franklin, P. Stewart. Antimicrobial Agents and Chemotherapy, 2003
983 citations recorded by the source corpus.
Subfields: Microbiology, Molecular Biology, Molecular Medicine
View Paper: https://www.semanticscholar.org/paper/225681ecc5d7dedf0db6f2739fd0366d8fa11152
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Microbiology
In Molecular Biology
In Molecular Medicine
Citations in the corpus
- Signals, Regulatory Networks, and Materials That Build and Break Bacterial Biofilms (2009, background): “Studies using microelectrodes have shown that oxygen penetration into the biofilm core decreases with increasing biofilm thickness due to consumption of oxygen by the biofilm-based bacteria closest to the environmental interface (10, 340).”
- Bacterial Biofilms: Development, Dispersal, and Therapeutic Strategies in the Dawn of the Postantibiotic Era (2013, background): “…interactions and DNA exchange (Flemming and Wingender 2010; Koo et al. 2010), while protecting the biomass from desiccation, predation, oxidizing molecules, radiation, and other damaging agents (Walters et al. 2003; Jefferson et al. 2005; Mai-Prochnow et al. 2008; Flemming and Wingender 2010).”
- Surviving as a community: antibiotic tolerance and persistence in bacterial biofilms (2019, background): “Cells buried inside thick biofilms could be in stationary phase, as penetration of nutrients and oxygen are known to be limited due to consumption by peripherally-located cells (Walters et al., 2003).”
- Bacterial Extracellular Polysaccharides in Biofilm Formation and Function (2015, background): “However, studies have demonstrated that several antibiotics can readily penetrate the bio fi lm (83, 84).”
- Antibiotic resistance of bacterial biofilms. (2010, neutral): “of biofilms to aminoglycosides and ciprofloxacin (69).”
- Biofilm-Related Infections: Bridging the Gap between Clinical Management and Fundamental Aspects of Recalcitrance toward Antibiotics (2014, background): “aeruginosa biofilms reduce tobramycin and ciprofloxacin bactericidal effects (42).”
- Physiological heterogeneity in biofilms (2008, methodology): “Another strategy for visualizing patterns of protein synthetic activity is to use an inducible GFP construc”
- Polymicrobial Interactions: Impact on Pathogenesis and Human Disease (2012, background): “Such microcommunities are highly recalcitrant to antibiotic therapy (200, 216).”
- Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action (2017, background): “interface, the part of the biofilm exposed to oxygen (50– 90 mm in the biofilm).(24) Moreover, studies also demon-”